Results 31 to 40 of about 70,002 (313)

New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review

Rheumatology International, 2022
Dermatomyositis is a rare, type I interferon-driven autoimmune disease, which can affect muscle, skin and internal organs (especially the pulmonary system).
M. Holzer, M. Krusche, N. Ruffer, Heinrich Haberstock, Marlene Stephan, T. Huber, I. Kötter   +6 more
semanticscholar   +1 more source

Association between a C8orf13-BLK polymorphism and polymyositis/dermatomyositis in the Japanese population: an additive effect with STAT4 on disease susceptibility. [PDF]

PLoS ONE, 2014
BACKGROUND:Accumulating evidence has shown that several non-HLA genes are involved in the susceptibility to polymyositis/dermatomyositis. This study aimed to investigate the involvement of C8orf13-BLK, one of the strongest candidate genes for autoimmune ...
Tomoko Sugiura, Yasushi Kawaguchi, Kanako Goto, Yukiko Hayashi, Takahisa Gono, Takefumi Furuya, Ichizo Nishino, Hisashi Yamanaka   +7 more
doaj   +1 more source

Anti-PL-7 antibody-positive dermatomyositis with progressive interstitial pneumonia complicated with tracheal ulcer

Respiratory Medicine Case Reports, 2021
Tracheobronchial lesions are rare extramuscular complications for idiopathic inflammatory myopathies including dermatomyositis. We herein report a 65-year-old woman with tracheal ulcer during the progression of dermatomyositis-associated interstitial ...
Shintaro Sato, Hideaki Yamakawa, Tamiko Takemura, Tomohiko Nakamura, Tomohiro Oba, Tomotaka Nishizawa, Rie Kawabe, Keiichi Akasaka, Masako Amano, Hidekazu Matsushima   +9 more
doaj   +1 more source

Incidence, Prevalence, and Mortality of Dermatomyositis: A Population‐Based Cohort Study

Arthritis care & research, 2021
We aimed to determine the population‐based incidence, prevalence, and mortality of dermatomyositis (DM) using European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) criteria.
V. Kronzer, B. Kimbrough, C. Crowson, John M. Davis, M. Holmqvist, F. Ernste   +5 more
semanticscholar   +1 more source

Prevalence and reactivity of anti-melanoma differentiation-associated gene 5 (anti-MDA-5) autoantibody in Brazilian patients with dermatomyositis [PDF]

Anais Brasileiros de Dermatologia, 2018
: Background: There have been no studies to date on the frequency and reactivity of aanti-melanoma differentiation-associated gene 5 (anti-MDA-5) in samples from the Brazilian population with dermatomyositis. Objectives: To analyze this autoantibody in
Isabela Bruna Pires Borges, Marilda Guimarães Silva, Samuel Katsuyuki Shinjo   +2 more
doaj   +1 more source

Development and validation of a nomogram risk prediction model for malignancy in dermatomyositis patients: a retrospective study [PDF]

PeerJ, 2021
Background Dermatomyositis accompanied with malignancy is a common poor prognostic factor of dermatomyositis. Thus, the early prediction of the risk of malignancy in patients with dermatomyositis can significantly improve the prognosis of patients ...
Jiaojiao Zhong, Yunan He, Jianchi Ma, Siyao Lu, Yushi Wu, Junmin Zhang   +5 more
doaj   +2 more sources

Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases.

Neurology, 2020
OBJECTIVES The predominance of extramuscular manifestations (e.g., skin rash, arthralgia, interstitial lung disease [ILD]) as well as the low frequency of muscle signs in anti-melanoma differentiation-associated gene 5 antibody-positive (anti-MDA5 ...
Y. Allenbach, Y. Uzunhan, S. Toquet, G. Leroux, L. Gallay, Alicia Marquet, A. Meyer, C. Guillaud, N. Limal, F. Gagnadoux, B. Hervier, R. Borie, C. Deligny, B. Terrier, A. Bérézné, S. Audia, N. Champtiaux, H. Devilliers, N. Voermans, E. Diot, A. Servettaz, T. Marhadour, V. Castelain, S. Humbert, C. Blanchard-Delaunay, N. Tieulié, P. Charles, M. Gérin, A. Mékinian, P. Priou, J. Meurice, A. Tazi, V. Cottin, M. Miyara, B. Grange, D. Israëł-Biet, S. Phin-Huynh, C. Bron, L. de Saint Martin, N. Fabien, K. Mariampillai, H. Nunes, O. Benveniste   +42 more
semanticscholar   +1 more source

A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies [PDF]

, 2011
Objectives: The paediatric idiopathic inflammatory myopathies (IIMs) are a group of rare chronic inflammatory disorders of childhood, affecting muscle, skin and other organs.
Bohan, Bohan, Brown, Chinoy, Chinoy, Christen-Zaech, Clarissa A. Pilkington, Constantin, Elst, Gunawardena, Gunawardena, Huber, Huber, Huber, Huber, Isenberg, Joyce E. Davidson, Kevin Murray, Kim, Li, Li, Lovell, Lowry, Lucy R. Wedderburn, Maillard, Maillard, Marhaug, McCann, McCann, McCann, Mendez, Miller, Neil Martin, Pachman, Pachman, Petra Krol, Ravelli, Rider, Rider, Rider, Rider, Riley, Riley, Sally Smith, Salomonsson, Stringer, Symmons, Varsani, Wedderburn, Wedderburn, Wedderburn   +50 more
core   +1 more source

A case of dermatomyositis with anti-TIF1γ antibodies revealing isolated para-aortic lymphadenopathy metastatic recurrence of endometrial cancer: A case report

SAGE Open Medical Case Reports, 2020
Dermatomyositis is an inflammatory myopathy presenting with characteristic cutaneous eruption and may be accompanied by proximal muscle weakness. Dermatomyositis may represent a paraneoplastic syndrome in 15%–25% of cases and has rarely been associated ...
Darosa Lim, Océane Landon-Cardinal, Annie Belisle, Sandra Davar   +3 more
doaj   +1 more source

The myokine GDF-15 is a potential biomarker for myositis and associates with the protein aggregates of sporadic inclusion body myositis. [PDF]

, 2020
Background: The cytokine growth differentiation factor-15 (GDF-15) has been associated with inflammatory and mitochondrial disease, warranting exploration of its expression in myositis patients.
De Bleecker, Jan, De Paepe, Boel, Verhamme, Fien   +2 more
core   +2 more sources